Ghana Becomes First Country to Approve Oxford Malaria Vaccine

An Oxford University malaria vaccine has been approved for use in Ghana. It is the first time the shot has received regulatory approval anywhere in the world. Ghana's Food and Drugs Authority has approved the vaccine's use in children aged between five months to three years old.

Adrian Hill, chief investigator of the R21/Matrix-M vaccine programme and director of the university's Jenner Institute, said it marked the "culmination of 30 years of malaria vaccine research at Oxford with the design and provision of a high efficacy vaccine that can be supplied at adequate scale to the countries who need it most."

Ghana is ramping up efforts to combat the mosquito-borne disease that kills over 600,000 each year, most of them children in Africa.

InFocus

A health worker prepares the malaria vaccine (file photo).

Follow AllAfrica

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.